Innovative Bioelectric Approaches to Infectious Disease

“The most interesting target in infection may not be the microbe at all. It may be the host's own signaling.”

— Samir Awad, MD, Medical Director

For most of modern medicine, our strategy against infection has been to attack the invader. Antibiotics and antivirals do exactly that, and they have saved countless lives. But there is a second player we have largely treated as a passive backdrop: the host. Immune activity, wound repair, and even microbial virulence are governed in part by electrical signaling at the cellular level — and that opens a complementary line of attack aimed at the host's response rather than only at the pathogen.

I find this reframing clinically energizing. When antibiotics falter — as they increasingly do against resistant organisms — a therapy that helps the body's own defenses work better is not a competitor to antimicrobials but an ally.

A platform built around the patient

Electrome's infection-control concept integrates sensing, stimulation, and personalization, with continuous AI-driven monitoring to adapt as a situation evolves. The clearest near-term gains discussed in the research are in complex wounds — diabetic ulcers, pressure injuries, and surgical-site infections — precisely the cases that defy simple protocols and consume disproportionate resources.

White blood cells of the immune system. The front-line mechanisms under study are intuitive once you accept the electrical framing. Targeted signals may help with directed immune recruitment, bringing defenders to the site; with barrier restoration, rebuilding the tissue that keeps microbes out; and with biofilm disruption, unsettling the protective films that let bacteria resist treatment. I keep these in the investigational register on purpose, because that is where the honest evidence sits.

“The most interesting frontier in infection is the host's own signaling. That is a conversation we are just beginning to understand.”

— Samir Awad, MD, Medical Director

From static dressings to dynamic care

What attracts me most is the shift in posture — from static wound care to dynamic, personalized immune modulation. A dressing that simply covers is passive; a system that senses, responds, and learns is active medicine. Modular hardware with onboard analytics and cloud integration could make that approach deployable both in high-tech hospitals and in low-resource clinics.

Infectious disease and antimicrobial resistance remain among the most persistent global threats we face. The host's own signaling is a frontier we are only beginning to understand, with early study reaching toward pulmonary infections, sepsis, and viral syndromes. It is early, and I say so plainly — but it is a direction worth the careful work.

A 3D rendering of virus particles.